ME

MedPacto, Inc.

Develops biomarker-based precision therapies for oncology and other incurable diseases.

235980 | KO

Overview

Corporate Details

ISIN(s):
KR7235980000
LEI:
Country:
South Korea
Address:
서울특별시 서초구 명달로 92, 보림빌딩, 서초구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of innovative, biomarker-based therapeutics. Utilizing a genome-based drug discovery platform, the company aims to deliver precision medicine and personalized therapies. Its research and development pipeline focuses on creating first-in-class treatments for incurable diseases, with core areas in oncology, autoimmune disorders, metabolic diseases, and bone and joint diseases. A key scientific strategy includes modulating the tumor microenvironment to enhance the efficacy of anticancer drugs. The company is committed to transforming novel targets into therapeutic solutions for patients with unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.3 KB
2025-07-17 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-11 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (진행성 NSCLC를 대상으로 한 백토서팁과 더발루맙 병용요법의 제 1b/2a상,…
Korean 15.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.6 KB
2025-03-28 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.9 KB
2025-03-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-03-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 88.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.5 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 353.8 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.3 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 187.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.8 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 177.3 KB

Automate Your Workflow. Get a real-time feed of all MedPacto, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MedPacto, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MedPacto, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus
CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea
030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan
4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan
7379

Talk to a Data Expert

Have a question? We'll get back to you promptly.